Anti-BCMA CAR-T cell therapy
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Anti-BCMA CAR-T cell therapy, covering 2022-04-07 to 2026-03-17. Get the full timeline:
Most recent: Clinical Trial Update: Anti BCMA CAR- T Cell Therapy for Adults With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]